発表論文 2022年度

2022-2023

2022年度の発表論文数は16報です。
2023年度の論文はこちら、2024年度の論文はこちらからご確認ください。

  1. Mwikuma G, Hang’ombe MB*, Kainga H, Kallu AS, Nakajima C, Suzuki Y. “Determination of Prevalence and Antimicrobial Resistance of Enterococcus faecalis and Enterococcus faecium associated with poultry in four Districts of Zambia.” Antibiotics.,12(4),657,(2023 March 28)
    DOI: 10.3390/antibiotics12040657
  2. Gonzalez G, Hayes M, Balansay M, Underwood R, Balagot C, Pan R, Pineda K, Iniguez-Stevens E, Kriner P, Estrada I, Myers CA, Kajon AE. “Two novel recombinant human mastadenovirus D genotypes associated with acute respiratory illness.”J Med Virol, 95(3), e28653, (2023 Mar 10)
    DOI: 10.1002/jmv.28653
  3. Nakakubo S, Unoki Y, Kitajima K, Terada M, Gatanaga H, Ohmagari N, Yokota I, Konno S. “Serum lactate dehydrogenase level one week after admission is the strongest predictor of prognosis of COVID-19: a large ob-servational study using the COVID-19 Registry Japan” Viruses,15(3), 671,(2023 Mar 2)
    DOI: 10.3390/v15030671
  4. Okagawa T, Konnai S, Nakamura H, Ganbaatar O, Sajiki Y, Watari K, Noda H, Honma M, Kato Y, Suzuki Y, Maekawa N, Murata S, Ohashi K. “Enhancement of vaccine-induced T-cell responses by PD-L1 blockade in calves” Vaccines, 11(3), 559, (2023 Mar 1)
    DOI: 10.3390/vaccines11030559
  5. Kida H, Jiang J, Matsui Y, Takahashi I, Hasebe R, Kawamura D, Endo T, Shibayama H, Kondo M, Nishio Y, Nishida K, Matsuno Y, Oikawa T, Kubota SI, Hojyo S, Iwasaki N, Hashimoto S, Tanaka Y, Murakami M. “Dupuytren’s contracture-associated SNPs increase SFRP4 expression in non-immune cells including fibroblasts to enhance inflammation development” Int Immunol, 35(7), 303-312, (2023 Jan 31)
    DOI: 10.1093/intimm/dxad004
  6. Kishimoto M, Kajihara M, Tabata K, Itakura Y, Toba S, Ozono S, Sato Y, Suzuki T, Ito N, Changla K, Qiu Y, Mori-Kajihara A, Eto Y, Harima H, Mwizabi D, Hang’ombe BM, Hall WW, Takada A, Orba Y, Sawa H, Sasaki M. “Isolation and Characterization of Distinct Rotavirus A in Bat and Rodent Hosts.” J Virol, e0145522, (2023 Jan 31)
    DOI:  10.1128/jvi.01455-22
  7. Nakamura H, Konnai S, Okagawa T, Maekawa N, Sajiki Y, Watari K, Kamitani K, Saito M, Kato Y, Suzuki Y, Murata S, Ohashi K. “Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus” J Virol., e0143022,(2023 Jan 31)
    DOI:  10.1128/jvi.01430-22
  8. Takeuchi H, Nakajima C, Konnai S, Maekawa N, Okagawa T, Usui M, Tamura Y, Suzuki Y, Murata S, Ohashi K. “Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies.” PLoS One., 18(1):e0281171, (2023 Jan 26)
    DOI: 10.1371/journal.pone.0281171
  9. Le KT, Nguyen LT, Huynh LT, Chu DH, Nguyen LV, Nguyen TN, Tien TN, Matsuno K, Okamatsu M, Hiono T, Isoda N, Sakoda Y .”Genetic, Antigenic, and Pathobiological Characterization of H9 and H6 Low Pathogenicity Avian Influenza Viruses Isolated in Vietnam from 2014 to 2018″ Microorganisms., 11(2); 244,(2023 Jan 18)
    DOI:  10.3390/microorganisms11020244
  10. Sasaki M, Tabata K, Kishimoto M, Itakura Y, Kobayashi H, Ariizumi T, Uemura K, Toba S, Kusakabe S, Maruyama Y, Iida S, Nakajima N, Suzuki T, Yoshida S, Nobori H, Sanaki T, Kato T, Shishido T, Hall WW, Orba Y, Sato A, Sawa H. “S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters” Sci Transl Med.,15(679),eabq4064,(2023 Jan 18)
    DOI: 10.1126/scitranslmed.abq4064
  11. Ohno M, Sagata M, Sekiya T, Nomura N, Shingai M, Endo M, Kimachi K, Suzuki S, Thanh Nguyen C, Nakayama M, Ishigaki H, Ogasawara K, Itoh Y, Kino Y, Kida H. “Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.” Vaccine., 41(3); 787-794,(2023 Jan 16)
    DOI:  10.1016/j.vaccine.2022.12.020
  12. Inoue T, Shinnakasu R, Kawai C, Yamamoto H, Sakakibara S, Ono C, Itoh Y,Terooatea T, Yamashita K, Okamoto T, Hashii N, Ishii-Watabe A, Butler NS,Matsuura Y, Matsumoto H, Otsuka S, Hiraoka K, Teshima T, Murakami M, Kurosaki T. “Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees.” J Exp Med,220(2), e20221786,(2023 Feb 6),Epub 2022 Dec 13.
    DOI: 10.1084/jem.20221786
  13. Yandle Z, Gonzalez G, Carr M, Matthijnssens J, De Gascun C. ” A viral metagenomic protocol for nanopore sequencing of group A rotavirus.” J Virol Methods,312, 114664,(2023 Feb),Epub 2022 Dec 6.
    DOI: 10.1016/j.jviromet.2022.114664
  14. Maekawa N, Konnai S, Asano Y, Otsuka T, Aoki E, Takeuchi H, Kato Y, Kaneko MK, Yamada S, Kagawa Y, Nishimura M, Takagi S, Deguchi T, Ohta H, Nakagawa T, Suzuki Y, Okagawa T, Murata S, Ohashi K. ” Molecular characterization of feline immune checkpoint molecules and establishment of PD-L1 immunohistochemistry for feline tumors.” PLoS ONE,18(1), e0281143,(2023 Jan 26)
    DOI: 10.1371/journal.pone.281143
  15. Hiono T, Kobayashi D, Kobayashi A, Suzuki T, Satake Y, Harada R, Matsuno K, Sashika M, Ban H, Kobayashi M , Aoshima K, Takaya F, Fujita H, Isoda N, Kimura T, Sakoda Y. “Virological, pathological, and glycovirological investigations of an Ezo red fox and a tanuki naturally infected with H5N1 highly pathogenic avian influenza viruses in Hokkaido, Japan” Virology, 18(1):578, 35-44,(2023 Jan),Epub 2022 Nov 29.
    DOI: 10.1016/j.virol.2022.11.008
  16. Shimizu H, Kodama M, Matsumoto M, Orba Y, Sasaki M, Sato A, Sawa H, Nakayama KI. “LIGHTHOUSE illuminates therapeutics for a variety of diseases including COVID-19” iScience.,25(11),105314,(2022 Oct 10)
    DOI: 10.1016/j.isci.2022.105314